(Sharecast News) - Tissue Regenix announced on Friday that its chief financial officer Kirsten Lund had joined the company's board with immediate effect.
The AIM-traded regenerative medical devices group confirmed the appointment following its earlier announcement on 16 October.

Lund, 41, owns 113,557 company shares.

At 1235 BST, shares in Tissue Regenix Group were down 9.67% at 8.13p.

Reporting by Josh White for Sharecast.com.

• News Channel